92197-46-1Relevant articles and documents
An improved and scalable process for 3,8-diazabicyclo[3.2.1]octane analogues
Huang, Long Jiang,Teng, Da Wei
experimental part, p. 523 - 526 (2012/01/30)
An improved and scalable process for substituted 3,8-diazabicyclo[3.2.1] octane was developed. N-Benzyl-2,5-dicarbethoxy-pyrrolidine 2 was reduced to N-benzyl-2,5-dihydroxymethylpyrrolidine 9 and subsequently debenzylated to afford N-Boc-2,5-dihydroxymeth
Diazabicyclooctane derivatives and therapeutic uses thereof
-
, (2008/06/13)
The present invention provides diazabicyclooctane derivatives of formula (I): and pharmaceutically acceptable salts thereof, wherein the group represents R1 and R2 are selected independently from H, (C1-C6)alkyl
Diazabicyclooctane derivatives and therapeutic uses thereof
-
Page 18, (2008/06/13)
The present invention provides diazabicyclooctane derivatives of formula (I): and pharmaceutically acceptable salts thereof, wherein the group representsR1 and R2 are selected independently from H, (C1-C6)alkyl,
3-Alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds
-
, (2008/06/13)
The invention relates to an antimicrobial compound of the formula: STR1 in which R1 is carboxy or protected carboxy, R2 is hydroxy(lower)alkyl or protected hydroxy(lower)alkyl, R3 and R4 are each hydrogen or low